ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0793

Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation

Norman Gaylis1, Odense DeLaRosa1, Nayak Polissar2, Nirnaya Miljacic2 and Andrew Holman3, 1Arthritis & Rheumatic Disease Specialties, Aventura, FL, 2Mountain Whisper Light, Seattle, WA, 3Inmedix Inc, Seattle, WA

Meeting: ACR Convergence 2022

Keywords: Cognitive dysfunction, COVID-19, Fatigue, pain, quality of life

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: Infection-related Rheumatic Disease Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Up to 70% of the 236 million people who have been diagnosed with SARS-CoV-2 develop post-COVID symptoms. (1) This has been defined by the NIH as Long COVID. These individuals present with multiple symptoms and organ involvement. Autonomic nervous system (ANS) dysfunction has been reported as a potential contributor to these complaints. (2) This is the first report of next-generation heart rate variability (HRV).

Methods: Patients with Long-COVID (definitive diagnostic evidence and symptoms for post COVID for a least 3 months) were evaluated in a single COVID clinic in Florida. These patients had multiple symptoms of various types as illustrated in the chart below. ANS function in all patients was measured by a next-generation version of 5-minute resting heart rate HRV predominately used currently to assess ANS function in elite professional athletes. Both 1996 standard time-and frequency-domain (3) and 2002 Bayevsky (4) ANS calculation outputs were assessed (Omegawave Oy, Espoo, Finland).

Results: Fifty-five percent of 40 patients with Long COVID tested (mean age 43 yrs. with a mean symptom duration of 15 months) showed findings of dysautonomia by abnormal resting HRV. Nearly all (97.5%) had combinations of symptoms (mean 5.0 [ range 1-9]) with age trending positive with more symptoms . Tabulated features are noted below. Fatigue (80%), joint pain (45%), dyscognition (72.5%), depression or anxiety (35%) were the predominant symptoms. In the symptomatic group with positive findings of autonomic dysfunction parasympathetic activity was low in 86% of these patients and sympathetic activity was increased in 50% of the patients; the overall level of tension (sympathetic) was abnormal in all these of the noted patients.

Conclusion: Long COVID is a complex complication of acute COVID infection and because of their multisystem presentation many of these patients are finding themselves being evaluated by rheumatologists. In many ways, the multi-system presentation, the abnormality in immunologic function and cytokine activity is comparable to the presentation of autoimmune diseases commonly seen by rheumatologists. We report autonomic dysregulation documented by next-generation HRV is a prominent finding of this patient population and may offer a novel explanation for Long COVID and allow us to eventually understand and treat this often very debilitating disorder.

References:
1. Lancet Respir Med. 2021 Nov;9(11):1275-1287. doi: 10.1016/S2213-2600(21)00383-0. Epub 2021 Oct 7.
2. Clin Med (Lond). 2021 Jan;21(1):e63-e67. doi: 10.7861/clinmed.2020-0896. Epub 2020 Nov26. PMID: 33243837; PMCID: PMC7850225.
3. Eur Heart J. 1996 Mar;17(3): 354-81.
4. Bayevsky RM, Ivanov GG, Chireykin GG, et al. HRV Analysis under the usage of different electrocardiography systems prepared according to the order of the Committee of Clinic Diagnostic Apparatus and the Committee of New Medical Techniques of Ministry of Health of Russia (protocol №4 from the 11APR2002).

Supporting image 1


Disclosures: N. Gaylis, Inmedix; O. DeLaRosa, None; N. Polissar, None; N. Miljacic, None; A. Holman, Inmedix.

To cite this abstract in AMA style:

Gaylis N, DeLaRosa O, Polissar N, Miljacic N, Holman A. Autonomic Nervous System Dysfunction Common Among Patients with Long COVID: An Exploratory Evaluation [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/autonomic-nervous-system-dysfunction-common-among-patients-with-long-covid-an-exploratory-evaluation/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/autonomic-nervous-system-dysfunction-common-among-patients-with-long-covid-an-exploratory-evaluation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology